CN102918064B - 在自组装单层上固定链霉亲和素的方法 - Google Patents
在自组装单层上固定链霉亲和素的方法 Download PDFInfo
- Publication number
- CN102918064B CN102918064B CN201180026951.0A CN201180026951A CN102918064B CN 102918064 B CN102918064 B CN 102918064B CN 201180026951 A CN201180026951 A CN 201180026951A CN 102918064 B CN102918064 B CN 102918064B
- Authority
- CN
- China
- Prior art keywords
- amino acid
- acid
- chemical formula
- glycine
- streptavidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108010090804 Streptavidin Proteins 0.000 title claims abstract description 65
- 239000002094 self assembled monolayer Substances 0.000 title claims abstract description 46
- 239000013545 self-assembled monolayer Substances 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 44
- 230000003100 immobilizing effect Effects 0.000 title abstract 2
- 229940024606 amino acid Drugs 0.000 claims description 101
- 235000001014 amino acid Nutrition 0.000 claims description 101
- 150000001413 amino acids Chemical class 0.000 claims description 101
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 89
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 74
- 229930182817 methionine Natural products 0.000 claims description 52
- 239000000126 substance Substances 0.000 claims description 46
- 239000004471 Glycine Substances 0.000 claims description 45
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 37
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 37
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 37
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 37
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 37
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 37
- 229960002989 glutamic acid Drugs 0.000 claims description 37
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 37
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 37
- 229960005190 phenylalanine Drugs 0.000 claims description 37
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 37
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 31
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 30
- 235000003704 aspartic acid Nutrition 0.000 claims description 30
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 30
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 24
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 24
- 239000004472 Lysine Substances 0.000 claims description 24
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 24
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 23
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 23
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 23
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 23
- 239000006035 Tryptophane Substances 0.000 claims description 23
- 229960003136 leucine Drugs 0.000 claims description 23
- 229960004799 tryptophan Drugs 0.000 claims description 23
- -1 Serine Chemical compound 0.000 claims description 21
- 239000000463 material Substances 0.000 claims description 21
- 239000013077 target material Substances 0.000 claims description 20
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 16
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 16
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 16
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 16
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 16
- 239000004473 Threonine Substances 0.000 claims description 16
- 229960000310 isoleucine Drugs 0.000 claims description 16
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 16
- 229960001153 serine Drugs 0.000 claims description 16
- 229960002898 threonine Drugs 0.000 claims description 16
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 15
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 claims description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 11
- 239000004475 Arginine Substances 0.000 claims description 9
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 9
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 9
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 9
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 8
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 8
- 229960002743 glutamine Drugs 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims description 6
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 5
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 229960002685 biotin Drugs 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 238000005070 sampling Methods 0.000 claims description 3
- 230000000052 comparative effect Effects 0.000 description 8
- 240000006409 Acacia auriculiformis Species 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 241000252506 Characiformes Species 0.000 description 3
- 229930003756 Vitamin B7 Natural products 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 238000003380 quartz crystal microbalance Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000011735 vitamin B7 Substances 0.000 description 3
- 235000011912 vitamin B7 Nutrition 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229960001866 silicon dioxide Drugs 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/625—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier binding through the biotin-streptavidin system or similar
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2610/00—Assays involving self-assembled monolayers [SAMs]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
氨基酸 | 固定量 | |
实施例14 | 赖氨酸 | 33 |
实施例12 | 组氨酸 | 32.2 |
实施例9 | 苯丙氨酸 | 28.8 |
实施例11 | 半胱氨酸 | 26.9 |
实施例1 | 甘氨酸 | 25.6 |
实施例3 | 甲硫氨酸 | 25.6 |
实施例16 | 谷氨酸 | 24.2 |
实施例20 | 酪氨酸 | 24.1 |
实施例13 | 丙氨酸 | 21.8 |
实施例6 | 丝氨酸 | 20.5 |
实施例18 | 天冬氨酸 | 19.7 |
实施例8 | 天冬酰胺 | 18.6 |
实施例15 | 亮氨酸 | 12.9 |
实施例10 | 色氨酸 | 12 |
实施例2 | 苏氨酸 | 9.1 |
实施例4 | 异亮氨酸 | 6.4 |
实施例17 | 缬氨酸 | 6.1 |
实施例7 | 谷氨酰胺 | 3.6 |
实施例5 | 脯氨酸 | 3.1 |
比较例19 | 精氨酸 | 2.5 |
比较例 | (无) | 1 |
Claims (22)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010191796 | 2010-08-30 | ||
JP2010-191796 | 2010-08-30 | ||
PCT/JP2011/001185 WO2012029202A1 (en) | 2010-08-30 | 2011-03-01 | A method for immobilizing streptavidin on a self-assembled monolayer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102918064A CN102918064A (zh) | 2013-02-06 |
CN102918064B true CN102918064B (zh) | 2015-03-11 |
Family
ID=45772330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180026951.0A Expired - Fee Related CN102918064B (zh) | 2010-08-30 | 2011-03-01 | 在自组装单层上固定链霉亲和素的方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US8785143B2 (zh) |
JP (1) | JP5149992B2 (zh) |
CN (1) | CN102918064B (zh) |
WO (1) | WO2012029202A1 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4921615B2 (ja) | 2010-01-25 | 2012-04-25 | パナソニック株式会社 | プロテインaを自己組織化膜上に固定する方法 |
JP5149992B2 (ja) | 2010-08-30 | 2013-02-20 | パナソニック株式会社 | ストレプトアビジンを自己組織化膜上に固定する方法 |
JP5108166B2 (ja) | 2010-10-19 | 2012-12-26 | パナソニック株式会社 | グルコースオキシダーゼを自己組織化膜上に固定する方法 |
WO2012168988A1 (ja) * | 2011-06-10 | 2012-12-13 | パナソニック株式会社 | 抗体を自己組織化膜上に固定する方法 |
JPWO2013008280A1 (ja) * | 2011-07-08 | 2015-02-23 | パナソニックヘルスケア株式会社 | タンパク質を自己組織化膜上に固定する方法 |
EP2796859A1 (en) * | 2013-04-25 | 2014-10-29 | Biocartis SA | Quantification of a functionalized surface |
WO2022020488A1 (en) * | 2020-07-21 | 2022-01-27 | Medtronic, Inc. | Electrochemical sensor with a diffusion control layer |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3804244A1 (de) | 1987-12-24 | 1989-07-06 | Boehringer Mannheim Gmbh | Verfahren zur bestimmung einer immunologisch aktiven substanz |
US5137804A (en) | 1988-05-10 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Assay device and immunoassay |
JPH07255013A (ja) | 1994-01-31 | 1995-10-03 | Sony Corp | 固体撮像装置 |
JP3385760B2 (ja) | 1994-02-21 | 2003-03-10 | ソニー株式会社 | 固体撮像装置及びその駆動方法 |
JP3695827B2 (ja) | 1996-03-13 | 2005-09-14 | 株式会社東芝 | 固体撮像装置 |
FI102922B1 (fi) | 1996-06-28 | 1999-03-15 | Valtion Teknillinen | Fluoresenssiin perustuva immunomääritysmenetelmä |
JP3579194B2 (ja) | 1996-09-17 | 2004-10-20 | 株式会社東芝 | 固体撮像装置の駆動方法 |
US6037577A (en) | 1997-03-11 | 2000-03-14 | Kabushiki Kaisha Toshiba | Amplifying solid-state image pickup device and operating method of the same |
JPH10257392A (ja) | 1997-03-14 | 1998-09-25 | Matsushita Electron Corp | 物理量分布検知半導体装置およびその駆動方法ならびにその製造方法 |
US5969758A (en) | 1997-06-02 | 1999-10-19 | Sarnoff Corporation | DC offset and gain correction for CMOS image sensor |
US6344877B1 (en) | 1997-06-12 | 2002-02-05 | International Business Machines Corporation | Image sensor with dummy pixel or dummy pixel array |
US6115066A (en) | 1997-06-12 | 2000-09-05 | International Business Machines Corporation | Image sensor with direct digital correlated sampling |
JPH1114627A (ja) | 1997-06-24 | 1999-01-22 | Sekisui Chem Co Ltd | 免疫学的診断試薬 |
JP3466886B2 (ja) | 1997-10-06 | 2003-11-17 | キヤノン株式会社 | 固体撮像装置 |
JPH11261046A (ja) | 1998-03-12 | 1999-09-24 | Canon Inc | 固体撮像装置 |
JP4200545B2 (ja) | 1998-06-08 | 2008-12-24 | ソニー株式会社 | 固体撮像素子およびその駆動方法、並びにカメラシステム |
US6794197B1 (en) | 1998-07-14 | 2004-09-21 | Zyomyx, Inc. | Microdevice and method for detecting a characteristic of a fluid |
US6682942B1 (en) | 1998-07-14 | 2004-01-27 | Zyomyx, Inc. | Microdevices for screening biomolecules |
US6576478B1 (en) | 1998-07-14 | 2003-06-10 | Zyomyx, Inc. | Microdevices for high-throughput screening of biomolecules |
US20030138973A1 (en) | 1998-07-14 | 2003-07-24 | Peter Wagner | Microdevices for screening biomolecules |
US7820393B2 (en) * | 1999-01-14 | 2010-10-26 | Scantibodies Laboratory, Inc. | Methods, kits and antibodies for detecting parathyroid hormone |
JP3621844B2 (ja) | 1999-02-24 | 2005-02-16 | シャープ株式会社 | 増幅型固体撮像装置 |
JP2001045375A (ja) | 1999-08-03 | 2001-02-16 | Canon Inc | 撮像装置とその読み出し方法 |
JP2001305139A (ja) | 2000-01-24 | 2001-10-31 | Nitto Denko Corp | 特異的結合体 |
JP3667186B2 (ja) | 2000-02-29 | 2005-07-06 | キヤノン株式会社 | 信号転送装置及びそれを用いた固体撮像装置 |
JP3628970B2 (ja) | 2001-02-08 | 2005-03-16 | 松下電器産業株式会社 | 固体撮像装置及びその駆動方法 |
JP4681767B2 (ja) | 2001-07-17 | 2011-05-11 | キヤノン株式会社 | 撮像装置およびカメラ |
EP1560939A4 (en) | 2001-08-27 | 2007-04-25 | Surface Logix Inc | IMMOBILIZATION OF BIOLOGICAL MOLECULES ON SURFACES COATED WITH MONOSLAYS |
WO2003054922A2 (en) | 2001-12-21 | 2003-07-03 | Koninklijke Philips Electronics N.V. | Image pick-up device and camera system comprising an image pick-up device |
JP3921093B2 (ja) | 2002-01-29 | 2007-05-30 | シャープ株式会社 | 増幅型固体撮像装置 |
JP4164733B2 (ja) | 2002-02-05 | 2008-10-15 | ソニー株式会社 | 固体撮像装置及びその駆動方法 |
DE60332005D1 (de) | 2002-02-12 | 2010-05-20 | Sony Corp | Festkörper-abbildungsvorrichtung und kamerasystem |
JP2003264745A (ja) | 2002-03-08 | 2003-09-19 | Sanyo Electric Co Ltd | 電荷転送装置 |
JP3969190B2 (ja) | 2002-05-30 | 2007-09-05 | ソニー株式会社 | 撮像信号処理方法、撮像信号処理装置、撮像装置 |
ES2279849T3 (es) | 2002-10-11 | 2007-09-01 | Imvision Gmbh | Moleculas transportadoras de antigenos modulares (moleculas mat) para la modulacion de reacciones inmunitarias, constructos, procedimientos y usos de las mismas. |
JP3988189B2 (ja) | 2002-11-20 | 2007-10-10 | ソニー株式会社 | 固体撮像装置 |
JP4355148B2 (ja) | 2003-02-28 | 2009-10-28 | パナソニック株式会社 | 固体撮像装置の駆動方法 |
JP4297416B2 (ja) | 2003-06-10 | 2009-07-15 | シャープ株式会社 | 固体撮像素子、その駆動方法およびカメラ |
JP2006166837A (ja) | 2004-12-17 | 2006-06-29 | Toyobo Co Ltd | リン酸化検出用アレイ |
JP4736439B2 (ja) | 2005-01-25 | 2011-07-27 | 東レ株式会社 | 核酸固定化担体 |
JP2006266707A (ja) | 2005-03-22 | 2006-10-05 | Fuji Photo Film Co Ltd | バイオセンサー |
EP1956372A4 (en) | 2005-11-30 | 2008-12-31 | Univ Nihon | ULTRA-HIGH RESPONSE FOR DETERMINING C REACTIVE PROTEIN AND DETERMINATION METHOD |
JP2007298334A (ja) | 2006-04-28 | 2007-11-15 | Mitsubishi Chemicals Corp | 糖類固定化体及びその利用 |
JP2009541259A (ja) * | 2006-06-20 | 2009-11-26 | ブラッコ・イメージング・ソシエタ・ペル・アチオニ | 糖抗原に対する特異抗体の製造方法 |
KR20090122439A (ko) * | 2007-02-21 | 2009-11-30 | 메다렉스, 인코포레이티드 | 단일 아미노산을 갖는 화학적 링커 및 이의 접합체 |
CA2690190A1 (en) | 2007-07-02 | 2009-01-08 | Genefluidics, Inc. | Chip assay having improved efficiency |
JP5175584B2 (ja) | 2008-03-13 | 2013-04-03 | 地方独立行政法人 東京都立産業技術研究センター | 局所表面プラズモン共鳴イメージング装置 |
JP2010117140A (ja) * | 2008-11-11 | 2010-05-27 | Panasonic Corp | アナライト分析方法 |
JP5342421B2 (ja) | 2009-03-11 | 2013-11-13 | 信越化学工業株式会社 | 分子固定用基板の製造方法 |
JP4921615B2 (ja) * | 2010-01-25 | 2012-04-25 | パナソニック株式会社 | プロテインaを自己組織化膜上に固定する方法 |
JP5149992B2 (ja) | 2010-08-30 | 2013-02-20 | パナソニック株式会社 | ストレプトアビジンを自己組織化膜上に固定する方法 |
JP5108166B2 (ja) | 2010-10-19 | 2012-12-26 | パナソニック株式会社 | グルコースオキシダーゼを自己組織化膜上に固定する方法 |
WO2012168988A1 (ja) | 2011-06-10 | 2012-12-13 | パナソニック株式会社 | 抗体を自己組織化膜上に固定する方法 |
JP5202762B2 (ja) | 2011-07-05 | 2013-06-05 | パナソニック株式会社 | アルブミンを自己組織化膜上に固定する方法 |
-
2011
- 2011-03-01 JP JP2011517140A patent/JP5149992B2/ja not_active Expired - Fee Related
- 2011-03-01 WO PCT/JP2011/001185 patent/WO2012029202A1/en active Application Filing
- 2011-03-01 CN CN201180026951.0A patent/CN102918064B/zh not_active Expired - Fee Related
-
2012
- 2012-09-27 US US13/629,121 patent/US8785143B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
Non-Patent Citations (1)
Title |
---|
The Biotin-(strept)Avidin System: Principles and Applications in Biotechnology;Eleftherios P. Diamandis等;《Clinical Chemistry》;19911231;第37卷(第5期);标题、摘要、图9、第632页左栏第2段 * |
Also Published As
Publication number | Publication date |
---|---|
JP5149992B2 (ja) | 2013-02-20 |
US20130023059A1 (en) | 2013-01-24 |
WO2012029202A1 (en) | 2012-03-08 |
US8785143B2 (en) | 2014-07-22 |
JP2012526725A (ja) | 2012-11-01 |
CN102918064A (zh) | 2013-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102725637B (zh) | 在自组装单层上固定a蛋白的方法 | |
CN102918064B (zh) | 在自组装单层上固定链霉亲和素的方法 | |
Altintas et al. | Integrated approaches toward high‐affinity artificial protein binders obtained via computationally simulated epitopes for protein recognition | |
CN103492879B (zh) | 将抗体固定到自组装膜上的方法 | |
Rahman et al. | An impedimetric immunosensor for the label-free detection of bisphenol A | |
Sharma et al. | A novel piezoelectric immunosensor for the detection of malarial Plasmodium falciparum histidine rich protein-2 antigen | |
JP5108166B2 (ja) | グルコースオキシダーゼを自己組織化膜上に固定する方法 | |
US7186799B2 (en) | Peptide and amine examination method using the same | |
Bottari et al. | Impedimetric sensing of the immuno-enzymatic reaction of gliadin with a collagen-modified electrode | |
Kim et al. | Dual synergistic response for the electrochemical detection of H1N1 virus and viral proteins using high affinity peptide receptors | |
Deng et al. | Quartz crystal microbalance bioaffinity sensor for biotin based on mixed self-assembled monolayers and metastable molecular complex receptor | |
KR100838323B1 (ko) | 비스페놀a 검출용 임피던스 면역센서 및 이를 이용한검출방법 | |
CN103562721B (zh) | 将白蛋白固定到自组装膜上的方法 | |
KR101402316B1 (ko) | 핵산 앱타머 및 항체를 이용한 에디포카인의 ELAAS(Enzyme-Linked Antibody Aptamer Sandwich) 검출방법 | |
JP2010002393A (ja) | 標的物質の検出方法 | |
KR20100008944A (ko) | 금 나노입자에 의한 신호증폭 원리의 수정진동자면역센서를 이용한 c-반응성 단백의 초고감도 측정방법 | |
Yoo et al. | A radioimmunoassay method for detection of DNA based on chemical immobilization of anti-DNA antibody | |
WO2013008280A1 (ja) | タンパク質を自己組織化膜上に固定する方法 | |
Yao et al. | Differential Binding Kinetics for Evaluating Immune Checkpoint Inhibitors in Serum | |
TWI322819B (en) | Peptide and method for dectecing amine using the same | |
TWI322818B (en) | Peptide and method for dectecing amine using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: PANASONIC HEALTHCARE + MEDICAL EQUIPMENT CO., LTD. Free format text: FORMER OWNER: MATSUSHITA ELECTRIC INDUSTRIAL CO, LTD. Effective date: 20140422 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140422 Address after: Japan Ehime Applicant after: Panasonic Healthcare Co., Ltd Address before: Osaka Japan Applicant before: Matsushita Electric Industrial Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: PANASONIC HEALTHCARE HOLDINGS CO., LTD. Free format text: FORMER OWNER: PANASONIC HEALTHCARE + MEDICAL EQUIPMENT CO., LTD. Effective date: 20150123 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150123 Address after: Tokyo, Japan Applicant after: Panasonic's health medical treatment is controlled interest Co., Ltd. Address before: Japan Ehime Applicant before: Panasonic Healthcare Co., Ltd |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150311 Termination date: 20170301 |
|
CF01 | Termination of patent right due to non-payment of annual fee |